Effect of extra virgin olive oil consumption on glycemic control: A systematic review and meta-analysis.
Adult
Aged
Aged, 80 and over
Biomarkers
/ blood
Blood Glucose
/ metabolism
Diet, Healthy
Fatty Acids
/ administration & dosage
Female
Glycated Hemoglobin
/ metabolism
Glycemic Control
Homeostasis
Humans
Male
Middle Aged
Olive Oil
/ administration & dosage
Phenols
/ administration & dosage
Randomized Controlled Trials as Topic
Young Adult
Extra virgin olive oil
Fasting blood sugar
Glycemic control
Insulin
Journal
Nutrition, metabolism, and cardiovascular diseases : NMCD
ISSN: 1590-3729
Titre abrégé: Nutr Metab Cardiovasc Dis
Pays: Netherlands
ID NLM: 9111474
Informations de publication
Date de publication:
30 06 2021
30 06 2021
Historique:
received:
04
10
2020
revised:
12
02
2021
accepted:
16
02
2021
pubmed:
5
5
2021
medline:
28
9
2021
entrez:
4
5
2021
Statut:
ppublish
Résumé
Several health benefits are contributed to extra virgin olive oil (EVOO). The polyphenol fraction of EVOO may be responsible for its cardioprotective impacts. This systematic review and meta-analysis aimed to investigate the effect of EVOO intake on glycemic parameters. Electronic literature searched through 1 September 2020 across MEDLINE/PubMed, Web of Science, and SCOPUS databases to find all clinical trials that reported the effect of EVOO intake on glycemic parameters [FBS(fasting blood glucose), insulin, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) and HbA1c (glycated hemoglobin A1c)] vs. control. We pooled standardized mean differences (SMD) and 95% confidence intervals (CIs) from randomized clinical trials (RCTs) using random-effects models. Heterogeneity was assessed by Cochran Q-statistic and quantified (I Although EVOO seems a promising hypoglycemic effects, we did not find any significant evidence that EVOO consumption impacts glucose homeostasis. Furthermore, well-designed RCTs with longer durations are still needed to evaluate the EVOO's efficacy on glycemic parameters.
Identifiants
pubmed: 33941427
pii: S0939-4753(21)00086-7
doi: 10.1016/j.numecd.2021.02.017
pii:
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Fatty Acids
0
Glycated Hemoglobin A
0
Olive Oil
0
Phenols
0
hemoglobin A1c protein, human
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1953-1961Informations de copyright
Copyright © 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest All authors have no conflict of interest to declare.